FDA Approves First Nasal Spray for Treatment of Anaphylaxis
http://www.fda.gov/news-events/press-announcements/fda-approves-first-nasal-spray-treatment-anaphylaxis
FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose
http://www.fda.gov/news-events/press-announcements/fda-approves-first-nalmefene-hydrochloride-auto-injector-reverse-opioid-overdose
FDA Roundup: August 6, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-august-6-2024
FDA Roundup: August 2, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-august-2-2024
FDA Approves First Gene Therapy to Treat Adults with Metastatic Synovial Sarcoma
http://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treat-adults-metastatic-synovial-sarcoma
FDA Roundup: July 30, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-july-30-2024
FDA Roundup: July 26, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-july-26-2024
FDA Roundup: July 23, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-july-23-2024
FDA Roundup: July 16, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-july-16-2024
FDA, FTC Continue Joint Effort to Protect Consumers Against Companies Illegally Selling Copycat Delta-8 THC Food Products
http://www.fda.gov/news-events/press-announcements/fda-ftc-continue-joint-effort-protect-consumers-against-companies-illegally-selling-copycat-delta-8
